Apotheek Gilain SRL

Apotheek Gilain reported total assets of 705,776 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jun 2026).

Company number (CBE) 0746.508.634 · VAT BE0746508634
3300 Tienen
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 25 Apr 2020 (≈ 6 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheek Gilain shows with a free account.

See the score
Profile
SRL since 2020
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result35,550 €
Equity240,126 €
Cash163,054 €
EBITDA121,718 €
Total assets705,776 €
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +32 % Total assets -11 %

Accounts of the company itself (not consolidated).

The full file covers 5 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheek Gilain's annual accounts

20252024202320222021
Net result35,550 €
Equity240,126 €
Cash163,054 €
EBITDA121,718 €
Total assets705,776 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 09 Jun 2026
  • Year ended 31 Dec 2024filed on 28 Jun 2025
  • Year ended 31 Dec 2023filed on 30 Jul 2024
  • Year ended 31 Dec 2022filed on 31 Jul 2023
  • Year ended 31 Dec 2021filed on 29 Jul 2022

Apotheek Gilain's financial analysis

Management and control of Apotheek Gilain

4 active director(s) in the register.

Apotheek Gilain's shareholders and holdings →

Apotheek Gilain's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0746.508.634
VAT number
BE0746508634
Peppol
Registered · 0208:0746508634 · as of 10 Nov 2026
Legal form
SRL
Incorporated
25 Apr 2020
Registered office
3300 Tienen
Latest accounts
2025 · filed on 09 Jun 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheek Gilain (SRL) has been based in Tienen since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 35,550 € and equity of 240,126 €; its revenue is not published. Its solvency stands at 34.0%, below the median of its sector (44.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Apotheek Gilain

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheek Gilain

What is the revenue of Apotheek Gilain?

Apotheek Gilain files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Apotheek Gilain?

In Belgium, the VAT number is the company number prefixed with BE: BE0746508634 for Apotheek Gilain, if the company is VAT-registered. Its company number (CBE) is 0746.508.634.

Where is the registered office of Apotheek Gilain?

According to the CBE register, the registered office of Apotheek Gilain is in 3300 Tienen.

What is the equity of Apotheek Gilain?

At the close of the 2025 financial year, the equity of Apotheek Gilain amounts to 240,126 €, a solvency of 34.0% of total assets.

Who manages Apotheek Gilain?

The register lists 4 active mandates at Apotheek Gilain. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheek Gilain

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 19 Sep 2026

No credit card, no commitment.

What each plan unlocks →